Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,130	6,669	7,738	4,819	3,819	2,959
Trading Asset Securities	5,804	5,161	3,178	3,045	1,675	1,258
Cash & Short-Term Investments	10,934	11,830	10,916	7,863	5,494	4,217
Cash Growth	-6.56%	8.37%	38.82%	43.13%	30.28%	70.40%
Accounts Receivable	1,575	2,257	2,782	2,850	2,183	2,032
Other Receivables	31.5	12.5	14.99	17.2	11.98	10.33
Receivables	1,607	2,270	2,797	2,867	2,195	2,042
Inventory	344.74	569.09	490.08	391.48	375.59	278.42
Other Current Assets	59.95	32.6	32.5	54.23	58.34	38.13
Total Current Assets	12,945	14,702	14,235	11,177	8,123	6,576
Property, Plant & Equipment	2,512	2,706	2,922	2,856	3,034	3,141
Long-Term Investments	487.39	464.71	393.97	332.34	328.44	155.33
Goodwill	167.3	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	337.98	308.56	305.01	320.62	280.04	283.84
Long-Term Deferred Tax Assets	35.53	41.83	45.45	62.16	57.32	42.62
Long-Term Deferred Charges	5.78	2.38	11.91	3.87	13.19	23.67
Other Long-Term Assets	41.64	66.44	62.16	62.14	127.96	126.51
Total Assets	16,534	18,459	18,144	14,981	12,131	10,516
Accounts Payable	1,080	1,730	2,141	1,505	945.77	452.52
Accrued Expenses	99.59	254.87	246.62	350.39	242.7	207.74
Short-Term Debt	648.1	836.39	1,088	400	-	-
Current Portion of Long-Term Debt	-	-	-	-	627.55	-
Current Portion of Leases	40.15	1.07	1.06	0.44	1.55	-
Current Income Taxes Payable	152.04	99.77	182.62	106.09	43.71	69.64
Current Unearned Revenue	17.68	17.92	17.25	49.14	19.34	8.03
Other Current Liabilities	393.89	598.01	915.86	1,016	919.98	1,229
Total Current Liabilities	2,432	3,538	4,592	3,427	2,801	1,967
Long-Term Debt	37.18	-	-	-	-	602.58
Long-Term Leases	0.61	1.04	1.43	0.2	1.02	-
Long-Term Unearned Revenue	60.78	65.45	71.43	78.19	84.63	90.67
Long-Term Deferred Tax Liabilities	145.08	127.84	109.28	122.05	112.38	90.72
Other Long-Term Liabilities	0.44	0.53	0.82	1.06	1.35	1.67
Total Liabilities	2,676	3,733	4,775	3,629	3,000	2,753
Common Stock	452.17	452.69	452.74	452.74	436.27	436.26
Additional Paid-In Capital	3,999	4,012	3,999	3,984	3,148	3,114
Retained Earnings	9,448	10,345	9,010	6,998	5,431	4,112
Treasury Stock	-69.18	-108.57	-111.97	-97.18	-	-
Comprehensive Income & Other	-	-	-	-	100.81	100.87
Total Common Equity	13,829	14,702	13,349	11,337	9,117	7,763
Minority Interest	28.35	24.57	19.42	15.14	14.17	-
Shareholders' Equity	13,858	14,726	13,369	11,352	9,131	7,763
Total Liabilities & Equity	16,534	18,459	18,144	14,981	12,131	10,516
Total Debt	726.04	838.5	1,090	400.65	630.12	602.58
Net Cash (Debt)	10,208	10,992	9,826	7,463	4,864	3,615
Net Cash Growth	-2.55%	11.86%	31.67%	53.43%	34.56%	90.37%
Net Cash Per Share	11.11	11.98	10.72	8.22	5.40	4.33
Filing Date Shares Outstanding	906.07	912.53	921.81	921.82	888.27	888.26
Total Common Shares Outstanding	906.07	912.53	921.81	921.82	888.27	888.26
Working Capital	10,514	11,164	9,644	7,749	5,322	4,609
Book Value Per Share	15.26	16.11	14.48	12.30	10.26	8.74
Tangible Book Value	13,324	14,226	12,877	10,849	8,670	7,312
Tangible Book Value Per Share	14.71	15.59	13.97	11.77	9.76	8.23
Buildings	-	2,953	2,911	2,455	2,473	2,362
Machinery	-	1,728	1,685	1,644	1,566	1,488
Construction In Progress	-	156.63	186.98	352.15	322.17	364.89

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.